vancomycin has been researched along with Diseases, Peripheral Vascular in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baillon-Plot, N; Charbonneau, C; Corman, S; Eckmann, C; Haider, S; Lawson, W; Li, J; Macahilig, C; Nathwani, D; Solem, C; Stephens, J | 2 |
AbuRahma, AF; Campbell, JR; Emmett, M; Hass, SM; Modak, A; Mousa, AY; Nanjundappa, A; Srivastiva, M; Stone, PA | 1 |
Hoaglund, PA; Shoultz, DA; Tice, AD | 1 |
1 trial(s) available for vancomycin and Diseases, Peripheral Vascular
Article | Year |
---|---|
Prospective randomized double-blinded trial comparing 2 anti-MRSA agents with supplemental coverage of cefazolin before lower extremity revascularization.
Topics: Adult; Aged; Antibiotic Prophylaxis; Cefazolin; Chi-Square Distribution; Daptomycin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lower Extremity; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Safety; Peripheral Vascular Diseases; Preoperative Care; Prospective Studies; Radiography; Risk Assessment; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures | 2015 |
3 other study(ies) available for vancomycin and Diseases, Peripheral Vascular
Article | Year |
---|---|
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Diabetes Complications; Europe; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2015 |
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Daptomycin; Diabetes Complications; Europe; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin; Young Adult | 2015 |
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amputation, Surgical; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Diabetes Complications; Female; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Osteomyelitis; Outcome Assessment, Health Care; Penicillins; Peripheral Vascular Diseases; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin; Washington | 2003 |